TA Associates announces strategic growth investment in Elos Medtech – QNT Press Release

[ad_1]

TA Associates, the world’s leading growth private equity firm, today announced that it has completed most of its growth investments in Elos Medtech AB (NASDAQ: ELOS B), the world’s leading innovative full-service contract development and manufacturing in the medical field Organization (CDMO). Equipment market.

This press release features multimedia. View the full version here: https://www.businesswire.com/news/home/20210726005835/en/

Founded in 1923, Elos Medtech is headquartered in Gothenburg, Sweden, and operates in factories in Sweden, Denmark, China and the United States. As a global solution partner, Elos Medtech provides complete performance and vertical integration for the world’s leading medical device companies. Elos Medtech serves Dental, orthopedics and life science markets. Through long-term cooperation with customers, Elos Medtech provides sustainable and innovative products and supply solutions for the global medical device and life science markets.

Lovisa Lander, the head of TA, said: “We have been following Elos Medtech for many years and are impressed by the company and its management team.” “Given its good reputation for quality and reliability, we believe that Elos Medtech is the world’s leading medical technology. The preferred partner of life science companies with the ability to further expand market share. With our knowledge, network and financial resources, we believe that TA can support the investment needed to help the company continue its growth journey. We look forward to working with the Elos Medtech team , To consolidate its focus as a global, high-quality development and manufacturing partner through MedTech.”

“I am very happy to welcome TA…

The full story on Benzinga.com

[ad_2]

Source link